Skip to main content
Clinical Trials/NCT05485038
NCT05485038
Suspended
Not Applicable

General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas: a Randomised, Controlled Trial

Sklifosovsky Institute of Emergency Care1 site in 1 country72 target enrollmentStarted: September 1, 2022Last updated:

Overview

Phase
Not Applicable
Status
Suspended
Sponsor
Sklifosovsky Institute of Emergency Care
Enrollment
72
Locations
1
Primary Endpoint
Composite event of deterioration of early motor function, severe disturbance of consciousness or death from any cause

Overview

Brief Summary

Objective of the study is to determine whether resection of gliomas and metastases of motor areas using awake surgery can achieve rarer motor deterioration after operation than using general anesthesia.

Detailed Description

Awake surgery is usually used for tumor resection located in language areas. But patient's awakening during removal of mass lesions from motor areas can give additional opportunities. Besides checking of muscle contractions and integrity of motor fibers a surgeon in awake patient can assess planning of movements, praxis, visual feedback and vestibular processing of motions. Preserving of voluntary movements can be an additional proof that cortical motor centers and corticospinal tract were not damaged. At the moment there are no published results of randomized trials showing advantage of awake surgery in removal of mass lesions from motor brain areas.

Objective of the study is to determine whether resection of gliomas and metastases of motor areas using awake surgery can achieve rarer motor deterioration after operation than using general anesthesia.

Participants of the study will be randomly operated using awake surgery or general anesthesia. In both groups intraoperative neuromonitoring will be used. Dynamics of motor functions will be assessed before and after surgery by blinded neurologists.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Dynamics of motor function before, within 10 days after surgery and in 3 months after surgery will be assessed by neurosurgeon blinded for the treatment arm

Eligibility Criteria

Ages
18 Years to 69 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • single gliomas without contrast enhancement in preoperative magnetic resonance imaging (presumed low-grade gliomas)
  • single gliomas with contrast enhancement in preoperative magnetic resonance imaging (presumed high-grade gliomas)
  • one or several brain metastases from any cancer
  • location near primary motor area or corticospinal tract
  • newly diagnosed
  • Karnofsky Performance Status 60-100%
  • muscle strength in assessed limbs 3-5 points in Medical Research Council scale
  • age 18-69 years
  • body mass index 29 and less
  • hemoglobin 110 and more

Exclusion Criteria

  • chronic obstructive pulmonary disease
  • persistent smoker (smoking index 11 and more)
  • major comorbidities
  • implanted pacemaker
  • inability to perform intraoperative tests before surgery
  • severe aphasia
  • psychiatric disorders
  • barely controlled seizures
  • contraindications to magnetic resonance imaging
  • previously performed brain radiotherapy

Outcomes

Primary Outcomes

Composite event of deterioration of early motor function, severe disturbance of consciousness or death from any cause

Time Frame: within 10 days after surgery

Motor function is assessed in Medical Research Council scale and is compared before and after surgery, deterioration of motor function means decline of 1 grade or more; level of consciousness is assessed in Glasgow Coma scale, it's severe disturbance means decline to 9 points or less

Dynamics of early motor function (in grades)

Time Frame: within 10 days after surgery

Early motor function is assessed in Medical Research Council scale and is compared before and after surgery

Dynamics of late motor function (in grades)

Time Frame: in 3 months after surgery

Late motor function is assessed in Medical Research Council scale and is compared before and in 3 months after surgery

Secondary Outcomes

  • Duration of hospital stay (in days)(From admission to the hospital till hospital discharge, up to 365 days)
  • Repeated hospital admission (Yes or No)(within 3 months after surgery)
  • Composite event of deterioration of early speech, severe disturbance of consciousness or death from any cause(within 10 days after surgery)
  • Early speech function (in grades)(within 10 days after surgery)
  • Early Karnofsky performance status (in percents)(within 10 days after surgery)
  • Duration of surgery (in minutes)(Intraoperatively)
  • Cerebral complications(within 3 months after surgery)
  • Somatic complications(From admission to intensive care unit after surgery till hospital discharge, up to 365 days)
  • Extent of resection (in percents)(within 48 hours after surgery)
  • Gross total resection (Yes or No)(within 48 hours after surgery)
  • Intraoperative blood loss (in milliliters)(Intraoperatively)
  • Duration of stay in intensive care unit (in days)(From admission to intensive care unit after surgery till transfer to neurosurgical unit, up to 365 days)
  • Late speech function (in grades)(in 3 months after surgery)
  • Late Karnofsky performance status (in percents)(in 3 months after surgery)

Investigators

Sponsor
Sklifosovsky Institute of Emergency Care
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Alexander Dmitriev

Principal Investigator

Sklifosovsky Institute of Emergency Care

Study Sites (1)

Loading locations...

Similar Trials